Why is Venmax Drugs falling/rising?

As of 28-Oct, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 27.88, reflecting a decrease of 0.37, or 1.31%. The stock has been underperforming its sector, with a performance today that is down by 1.05%. It has experienced consecutive declines over the last two days, resulting in a total drop of 6.16%. Despite this recent downturn, the stock has shown strong performance over the past month, with a return of 25.93%, and a year-to-date increase of 54.55%. Additionally, Venmax is trading above its moving averages across various time frames, indicating a generally positive trend prior to the recent falls. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Venmax's short-term performance over the past week has outpaced the benchmark Sensex, which has only increased by 0.24%, while Venmax has risen by 3.07%. However, the stock's recent decline contrasts with its strong year-to-date performance compared to the Sensex's 8.30% increase. This suggests that while the stock has been performing well overall, recent market dynamics may be affecting investor sentiment, leading to the current price drop.